Hemimegalencephaly Program

Provider Resources

Refer a Patient

Providers who would like to refer a patient to be evaluated for our innovative hemimegalencephaly treatment can email us or contact the Neonatal Neurology and Neonatal Neurocritical Care Program at 202-476-2120.

A strategy for the initial management of catastrophic holohemispheric epilepsy in the neonate

Read our published article (PDF) explaining in detail the Children’s National experience with two neonates with hemimegalencephaly and intractable seizures. You'll find detailed information about how we managed these patients using a strategy of initial minimally-invasive embolization of the cerebral blood supply to the involved hemisphere.

An innovative and effective treatment option for intractable seizures in newborns with hemimegalencephaly (HME)

Review our research poster (PDF) detailing our experience with five newborns with HME and intractable seizures who underwent staged targeted transarterial embolization (TAE).
Read our article in the Journal of NeuroInterventional Surgery explaining in detail the Children’s National experience with three neonates with hemimegalencephaly and intractable seizures. You'll find detailed information about how we managed intra-procedural events and the importance of a dedicated multidisciplinary team.